Sun Pharma subsidiary Taro acquires Antibe Therapeutics
Antibe Therapeutics is a clinical-stage biotechnological company based in Ontario, Canada
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Deals
Deal value declined by 86.4 per cent in Dec 2024, compared to Dec 2023
Three major deals contributed 70 per cent of the total deal value during December 2024
Lupin acquires Huminsulin from Eli Lilly
Lupin has been marketing the Huminsulin range of products through existing distribution and promotion agreements with Lilly, India…
Akums Group enters into a partnership for European market expansion
Under this collaboration, Akums Group will produce and supply multiple SKUs of oral liquid formulations, which the partner company…
Prothix LifeSciences partners with Oviya MedSafe
This partnership formalised through an MoU aims to leverage the business synergies between the two organisations to deliver…
Power Gummies raises ₹10 cr, aims to expand product range
The funding would be used to launch a zero-sugar range, upgrade compositions to make the brand sugar-free and diversify into…
Asahi Kasei Pharma enters into exclusive license agreement for anti-CX3CR1 Antibody
The anti-CX3CR1 antibody, currently in preclinical development, works by inhibiting CX3CR1, a receptor involved in immune cell…
M&A in pharma sees deals worth $14.8 bn in Nov 2024
According to GlobalData, M&A deal value declined by 2 per cent, and venture capital investments decreased by 5 per cent in…
Akums, Jagdale partner to manufacture aseptic carton packing for ready-to-drink nutritional…
The partnership aims to introduce non-milk-based aseptic carton packing solutions across key categories
Merck Life Science in India, Department for Promotion of Industry and Internal Trade sign an MoU
This collaboration under DPIIT's Startup India initiative aims to empower emerging biotech startups and provide access to global…
Merck Life Science in India, GeNext Genomics sign MoU
This collaboration aims to combine local expertise with global biomanufacturing capabilities
STEERLife and Callidus Research Laboratories partner to accelerate drug development
The collaboration combines STEERLife's advanced hot melt extrusion (HME) and continuous processing technologies with Callidus'…
ALK licenses rights to neffy, an adrenaline nasal spray for emergency treatment of anaphylaxis
ALK also gains rights to future indications, including acute urticaria flares (in development)
Alkem signs agreement with US-based Sonnet BioTherapeutics to develop, commercialise its drug…
Under the licensing agreement, Alkem will carry out the clinical development of “SON-080” in India to enable global and India…
Lupin partners with Takeda to commercialise Vonoprazan
The drug will be marketed under the brand name Lupin’s Lupivon and will be available in two strengths - 10 mg and 20 mg
Alkem signs non-exclusive patent license agreement with Takeda to commercialise Vonoprazan in India
Vonoprazan is used in the treatment of disorders related to Gastroesophageal Reflux Disease (GERD)
Pharma CMO M&A activity shifts focus to scaling in 2023: GlobalData
High inflation and interest rates along with an uncertain business environment have disincentivised investment. The focus shifts…
Merck signs an MoU with Aragen
The collaboration aims to facilitate the supply of equipment and technologies for mAb (monoclonal antibody) manufacturing and…
Industry reports 88 deals worth $11.1B in July 2024: GlobalData
The lifesciences sector also reported 73 VC deals worth $2.5 billion
Emcure signs PPA with Sunsure Energy for solar power
Through this partnership, Emcure and Gennova will receive approximately 36 million units of clean, renewable energy annually for…